CoChat

Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk‐1) following lentiviral‐mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model

Kyriakou, Chara A., Yong, Kwee L., Benjamin, Reuben, Pizzey, Arnold, Dogan, Ahmet, Singh, Nalini, Davidoff, Andrew M., Nathwani, Amit C. · 2006 · The Journal of Gene Medicine
Cited by 50

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Background: Efficient gene transfer to bone marrow derived mesenchymal stem cells (MSC) would provide an important opportunity to express potent anticancer agents in the tumour microenvironment because of their contribution to the tumour stroma. Methods: HIV‐based lentiviral vectors were pseudotyped with four different envelope proteins; amphotropic murine leukaemia virus (ampho), murine leukaemia virus (10A1), feline endogenous virus (RD114), and the vesicular stomatitis virus glycoprotein (VSVG). These pseudotypes were examined for transduction efficiency in human bone marrow derived MSC. The effect of lentiviral expression of truncated soluble vascular endothelial growth factor decoy receptor (tsFlk‐1) in MSC on growth of Raji cells was determined, both in vitro and in vivo. Results: All lentiviral vectors produced significant levels of transduction at an multiplicity of infection (MOI) of 1, those bearing the RD114 envelope glycoprotein consistently produced higher transduction levels (mean 70 ± 6%) compared with the other pseudotyped lentiviral vectors, although there was significant inter‐donor variation. Stable transgene expression was achieved after multiple rounds of transduction with VSVG‐pseudotyped particles, without alteration in the differentiative capacity of transduced cells. Co‐injection of MSC stably expressing tsFlk‐1 with Raji Burkitt's lymphoma cells significantly impaired subcutaneous tumour growth in immunodeficient mice when compared to controls where either unmanipulated MSC or GFP‐expressing MSC were used. Conclusions: Human MSC are easily transduced by pseudotyped lentiviral particles but there is inter‐donor variation in transduction efficiency. Gene‐modified MSC expressing a gene of therapeutic potential can moderate growth of haematological malignancies. Copyright © 2005 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jgm.840

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 35

  1. 10.1634/stemcells.20-3-205 · DOI · Paper page
  2. 10.1038/sj.thj.6200232 · DOI · Paper page
  3. 10.1073/pnas.1834138100 · DOI · Paper page
  4. 10.1161/hc0102.101442 · DOI · Paper page
  5. 10.1067/mtc.2000.110250 · DOI · Paper page
  6. Choi YS, 2003, A workshop on the marrow microenvironment and hematological malignancy, Cancer Res, 63, 7539
  7. 10.1016/S1470-2045(03)01195-1 · DOI
  8. 10.1080/10428190210188 · DOI
  9. 10.1080/14653240310000092 · DOI
  10. Ribatti D, 2001, Angiogenesis, angiogenic factor expression and hematological malignancies, Anticancer Res, 21, 4333
  11. 10.1182/blood-2002-06-1830 · DOI · Paper page
  12. 10.1038/6529 · DOI · Paper page
  13. 10.1016/S0301-472X(00)00482-3 · DOI · Paper page
  14. 10.1038/sj.gt.3302071 · DOI · Paper page
  15. 10.1080/14653240310001299 · doi:10.1080/14653240310001299
  16. 10.1126/science.1088547 · DOI · Paper page
  17. Naldini L, 1999, In vivo gene delivery by lentiviral vectors, Thromb Haemost, 82, 552, 10.1055/s-0037-1615879 · doi:10.1055/s-0037-1615879
  18. 10.1126/science.283.5402.682 · DOI · Paper page
  19. 10.1046/j.1365-2141.2002.03561.x · doi:10.1046/j.1365-2141.2002.03561.x
  20. 10.1182/blood-2003-06-1770 · DOI
  21. 10.1006/mthe.2002.0549 · DOI · Paper page
  22. Davidoff AM, 2002, rAAV‐mediated long‐term liver‐generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice, Cancer Res, 62, 3077
  23. 10.1073/pnas.90.17.8033 · DOI · Paper page
  24. 10.1128/JVI.78.3.1219-1229.2004 · DOI
  25. 10.1089/10430349950018157 · DOI · Paper page
  26. 10.1006/mthe.2002.0585 · DOI · Paper page
  27. 10.1038/nm0603-669 · DOI · Paper page
  28. 10.1007/s005990050018 · DOI
  29. 10.1016/S0301-472X(03)00159-0 · DOI
  30. Bachelder RE, 2001, Vascular endothelial growth factor is an autocrine survival factor for neuropilin‐expressing breast carcinoma cells, Cancer Res, 61, 5736
  31. 10.1016/S0092-8674(02)01229-1 · DOI · Paper page
  32. 10.1006/scbi.2000.0361 · DOI · Paper page
  33. Studeny M, 2003, Bone marrow‐derived mesenchymal stem cells as vehicles for interferon‐b delivery into tumors, Cancer Res, 62, 3603
  34. 10.1126/science.291.5503.447 · DOI · Paper page
  35. 10.1111/j.1749-6632.2003.tb03239.x · DOI

Cited by

See all 50

Metadata

Authors
Kyriakou, C. A., Yong, K. L., Benjamin, R., Pizzey, A., Dogan, A., Singh, N., Davidoff, A. M., & Nathwani, A. C.
Venue
The Journal of Gene Medicine
Publisher
Wiley
Published
2005-11-16
Volume
8
Issue
3
Pages
253-264
ISSN
  • 1099-498X (ISSN-L)
  • 1521-2254
OpenAlex
W2093817631
Cited by
50
References
1
FWCI
2.18
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk‐1) following lentiviral‐mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model. https://app.cochat.ai/papers/10.1002/jgm.840
The paper
Kyriakou, C. A., Yong, K. L., Benjamin, R., Pizzey, A., Dogan, A., Singh, N., Davidoff, A. M., & Nathwani, A. C. (2006). Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk‐1) following lentiviral‐mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.840

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.